FRED ALGER MANAGEMENT, LLC

Position in ABSI — Absci Corp

CIK 3520 NEW YORK, NY

Position in ABSI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,495,432

-$716,300 QoQ

Shares Held

1,165,144

-3.5% QoQ

Ownership

0.747%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FRED ALGER MANAGEMENT, LLC holds $649,233,872 across 51 Biotechnology names. ABSI ranks #19 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	3,342,493	$209,574,311
2	DNTH	Dianthus Therapeutics, Inc. /DE/	1,161,923	$97,508,578
3	ASND	Ascendis Pharma A/S	304,896	$69,738,861
4	COGT	Cogent Biosciences, Inc.	1,239,700	$47,716,053
5	FBRX	Forte Biosciences, Inc.	1,273,965	$32,995,693
6	ACAD	Acadia Pharmaceuticals Inc	1,277,151	$28,429,380
7	ROIV	Roivant Sciences Ltd.	925,186	$25,627,652
8	INSM	INSMED Inc	125,766	$20,565,256

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,495,432	1,165,144	-3.5%	Shares	Sole	2026-05-15
2025-12-31	$4,211,732	1,206,800	-2.1%	Shares	Sole	2026-02-17
2025-09-30	$3,748,152	1,232,945	-68.6%	Shares	Sole	2025-11-14
2025-06-30	$10,098,329	3,929,311	-8.5%	Shares	Sole	2025-08-14
2025-03-31	$10,778,020	4,294,032	-34.0%	Shares	Sole	2025-05-16
2024-12-31	$17,044,208	6,505,423	-14.0%	Shares	Sole	2025-02-14
2024-09-30	$28,904,480	7,566,618	+4.3%	Shares	Sole	2024-11-14
2024-06-30	$22,350,867	7,256,775	-2.0%	Shares	Sole	2024-08-14
2024-03-31	$42,076,355	7,407,809	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.